GLOMERULONEPHRITIS
(AGN)
Paediatric Department CME
Outline
Definition
Epidemiology
Aetiology
Clinical approach
Investigation
Management
Definition
Haematuria
Oliguria
Edema
Azotemia
Hypertension
Epidemiology
2. Systemic causes
Causes Features
Vasculitis Wegener’s granulomatosis
Collagen vascular diseases SLE
Polyarteritis nodosa Vasculitis involving renal arteries
Henoch Schonlein purpura Generalized vasculitis resulting in
gromerulonephritis
Goodpasture syndrome Circulating antibodies to type 4
collagen (against GBM,
pulmonary BM)
Drug induce Gold, penicillamine
Aetiology
Azotemia Oliguria
Hematuria
Fluid retention
through RAAS
Hypertension
History
Haematuria
Oliguria
Edema (85%)
Hypertension
Loin pain
2. Risk factors
3. Underlying diseases
4. Complications
1. Urinalysis
2. Serological tests
ASOT ( >200 U)
Anti-DNAse B (better indication of preceding streptococcal skin
infection)
Throat/skin swab
Investigation
Other options if BP still uncontrolled: Captopril (0.1-0.5 mg/kg q8 hourly) / Metoprolol 1-4 mg/kg 12
hourly
Management of hypertension in AGN
Symptomatic/severe hypertension
• Target of BP control:
- Reduce BP to <90th percentile of BP for age, gender
and height percentile .
- Total BP to be reduced = Observed mean BP −
Desired mean BP
- Reduce BP by 25% of target BP over 3 – 12 hours.
- The next 75% reduction is achieved over 48 hours.
Management of hypertension in AGN
Pulmonary
edema
Give oxygen
45 degrees, prop up
Close reassessment